A few years ago it looked likely that we’d discover a drug that might be taken prenatally by mothers whose children might have a high risk of CAH – in order to prevent it.
Since CAH is the only intersex condition that can necessitate medical treatment, and specifically might prevent an “adrenal crisis” that can be life threatening to a newborn with CAH – this development could have been a good thing.
Except that it’s off-label use it intended to prevent lesbians and tomboys. And career women. Depending on how exactly you’re going to define female masculinity.
It’s nice to see Slate finally reporting on it, despite the dumb-ass & sensationalist title of the article, & I’m hoping that means this question gets put to a much wider range of parents and potential parents.
Here’s the paper by Dreger, Feder and Tamar-Mattis.
Here’s a summation out of Northwestern.